Abstract

Phosphorylation of the ribosomal S6 subunit is tightly correlated with enhanced translation initiation of a subset of mRNAs that encodes components of the protein synthesis machinery, which is an important early event that controls mammalian cell growth and proliferation. The recently identified S6 kinase 2 (S6K2), together with its homologue S6K1, is likely responsible for the mitogen-stimulated phosphorylation of S6. Like S6K1, the activation of S6K2 requires signaling from both the phosphatidylinositol 3-kinase and the mammalian target of rapamycin (mTOR). Here we report the investigation of the mechanisms of S6K2 regulation by mTOR. We demonstrate that similar to S6K1 the serum activation of S6K2 in cells is dependent on mTOR kinase activity, amino acid sufficiency, and phosphatidic acid. Previously we have shown that mTOR is a cytoplasmic-nuclear shuttling protein. As a predominantly nuclear protein, S6K2 activation was facilitated by enhanced mTOR nuclear import with the tagging of an exogenous nuclear localization signal and diminished by enhanced mTOR nuclear export with the tagging of a nuclear export sequence. However, further increase of mTOR nuclear import by the tagging of four copies of nuclear localization signal resulted in its decreased ability to activate S6K2, suggesting that mTOR nuclear export may also be an integral part of the activation process. Consistently, the nuclear export inhibitor leptomycin B inhibited S6K2 activation. Taken together, our observations suggest a novel regulatory mechanism in which an optimal cytoplasmic-nuclear distribution or shuttling rate for mTOR is required for maximal activation of the nuclear S6K2.

Highlights

  • S6 kinase 2 (S6K2) activation in the presence of rapamycin was significantly restored by the rapamycin-resistant mammalian target of rapamycin (mTOR) (Fig. 1B), indicating that mTOR is the sole mediator of the rapamycin effect

  • Amino Acid Sufficiency Is Required for Mitogenic Activation of S6K2—Amino acid depletion leads to dephosphorylation and inactivation of S6 kinase 1 (S6K1) in a reversible manner via the mTOR pathway (6 – 8)

  • To test whether amino acid sufficiency is required for S6K2 activation, we examined the effect of amino acid deprivation on S6K2 activity

Read more

Summary

The abbreviations used are

S6K, S6 kinase; mTOR, mammalian target of rapamycin; PI3K, phosphatidylinositol 3-kinase; NLS, nuclear localization signal; Erk, extracellular signal-regulated kinase; PA, phosphatidic acid; LMB, leptomycin B; HA, hemagglutinin; HEK, human embryonic kidney; FBS, fetal bovine serum; FITC, fluorescein isothiocyanate; NES, nuclear export sequence. Two parallel pathways are both required for activation of S6K1, and they are mediated by the phosphatidylinositol 3-kinase (PI3K) and the mammalian target of rapamycin (mTOR), respectively (2, 5). The kinase activity of mTOR is required, but not sufficient, for signaling to downstream effectors including S6K1 (11, 12). The constant nuclear entry and exit of mTOR is necessary for mitogenic activation of S6K1 (14), the shuttling itself does not seem to be regulated by any known upstream signals.. Like S6K1, the activation of S6K2 requires both the PI3K pathway and the mTOR pathway (17, 18, 21) and involves the mitogen-activated protein kinase Erk (22, 23). Our data suggest that an optimal rate of mTOR cytoplasmic-nuclear shuttling gives rise to maximal activation of S6K2

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.